Because our work used a PAR1 null cell as the host for PAR1 expression, our data clearly demonstrate the oncogenic potential of PAR1 itself in a gastric cancer cell background, apart from factors other than PAR1 that can confer the oncogenic phenotype. This evidence concerns the gene F2R and gastric cancer.